Cytosorbents CorporationCTSONASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank93
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
33.37%
↑ 230% vs avg
Percentile
P93
Near historical high
Streak
3 yr
Consecutive growthAccelerating
Average
-25.62%
Historical baseline
PeriodValue
202433.37%
202323.30%
2022-101.59%
2021-149.51%
202066.51%
2019-54.61%
2018-67.78%
20174.02%
201625.29%
2015-35.25%